Article
Effect of Dapagliflozin on COVID-19 Infection and Risk of Hospitalization
2023-03-11
Abstract excerpt
Background and Aim: It has been suggested that dapagliflozin might mitigate cytokine production and inflammatory response, which could be of value in patients affected by COVID 19. Due to the paucity of data we aim to assess – by means of several objectives- the effect of dapagliflozin on 1) COVID19 severity: 1.1) risk of hospitalization 1.2) risk of intensive care unit (ICU) admission 1.3) In-hospital death 1.4)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e599a2e8-c983-5330-a094-0ea18edf09d7
- DOI
- 10.2139/ssrn.4383079
